Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?

Bibliography

• COCO AS: Primary dysmenorrhoea. Am. Fain. Physician (1999) 60(2):489–496.
   PubMed Web of Science ®Google Scholar
• PEDRON-NUWVO, GONZALEZ-UNZAGA R,DE CELLIS CARRILLO R et al.: Incidence of dysmenorrhoea and associated symptoms in women aged 12–24 years. Ginecol Obstet. Mex. (1998) 66:492–494.
   Google Scholar
• JAMIESON DJ, STEEGE JF: The prevalence of dysmenorrhoea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet. Gynecol (1996) 87:55–58.
   PubMed Web of Science ®Google Scholar
• ANDERSCH B, MILSOM I:An epidemiologic study of young women with dysmenorrhoea. Am. I Obstet. Gynecol (1982) 144:655–660.
   PubMed Web of Science ®Google Scholar
• DELIGEOROGLOU E: Dysmenorrhoea. Ann. NY Acad. Sri. (2000) 900:237–244.
   PubMed Web of Science ®Google Scholar
• SCHROEDER B, SANFILIPPO JS: Dysmenorrhoea and pelvic pain in adolescents. Pediati: Clin. North Am. (1999) 46(3):555–571.
   PubMedGoogle Scholar
• HARLOW SD, PARK M: A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br. .1. Obstet. Gynaecol (1996) 103:1134–1142.
   PubMedGoogle Scholar
• SUNDELL G, MILSOM I,ANDERSCH B: Factors influencing the prevalence and severity of dysmenorrhea in young women. Br. I Obstet. Gynaecol (1990) 97:588–594.
   PubMedGoogle Scholar
• PARAZZINI F, TOZZI L, MEZZOPANE R, LUCHINI L, MARCHINI M, FEDELE L: Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhoea. Epidemiology (1994) 5:469–472.
   PubMed Web of Science ®Google Scholar
• DAWOOD MY: Current concepts in the etiology and treatment of primary. Acta Obstet. Gynecol Scand. (1986) 138(Suppl.):7–10.
   Google Scholar
• BANIKARIM C, CHACKO MR, KELDER SH: Prevalence and impact of dysmenorrhoea on hispanic female adolescents. Arch. Pediati: Adolesc. Med. (2000) 154:1226–1229.
   PubMedGoogle Scholar
• HILLEN J, GRBAVAC S:Primary dysmenorrhoea in young western Australian woman: prevalence, impact and knowledge of treatment. I Adolesc. Health (1999) 25:40–45.
   PubMed Web of Science ®Google Scholar
• KLEIN J, LITT I: Epidemiology of adolescent dysmenorrhoea. Pedriatics (1981) 68:661–664.
   PubMed Web of Science ®Google Scholar
• FORLEO R, SBIROLI C, DI TONDO U: Mestruazione. Fisiopatologia della riproduzione femminile (Vol. 9). Gelmini (Ed.), Milano (1982):321–323.
   Google Scholar
• HUFFMAN JW, DEWHURST CJ, CAPRARO VJ: The Gynecology of Childhood and Adolescence. WB Saunders, Philadelphia, USA (1981):469–484.
   Google Scholar
• PICKLES VR: A plain muscle stimulant in the menstrum. Nature (1957) 180:1198–1199.
   PubMedGoogle Scholar
• SMITH RP, POWELL JR: The objective evaluation of dysmenorrhoea therapy. Am. J. Obstet. Gynecol (1980) 137:314–319.
   PubMedGoogle Scholar
• DAWOOD MY: Dysmenorrhoea.Clin. Obstet. Gynecol (1990) 33(1):168–178.
   Google Scholar
• CAMERON IT, CAMPBELL S:Nitric Oxide in the endometrium.Hum. Reprod. Update (1998) 4(5):565–569.
   Google Scholar
• BIEGLMAYER C, HOFER G, KAINZ C et al: Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol. (1995) 9:307–312.
   PubMed Web of Science ®Google Scholar
• NIGAM S, BENEDETTO C, ZONCA M et al: Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhoea. Eicosanoids (1991) 4:137–141.
   PubMedGoogle Scholar
• STOLL SL: Dysmenorrhoea.Secrets M Obstetrics and Ginecol (Vol. 4). (Ed) Italiana, Intramed Communications, Milan (1992):17–24.
   Google Scholar
• DAWOOD MY: Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.Drugs (1981) 22(1):42–56.
   PubMedGoogle Scholar
• REES MCP, ANDERSON ABM, DEMERS LM, TURNBULL A: Endometrial and myometrial prostaglandin released during the menstrual cycle in relation to menstrual blood loss.Clin. Endocrinol Metab. (1984) 58:813.
   Google Scholar
• ZONDERVAN KT, YUDKIN PL, VESSEY MP et al: The prevalence of chronic pelvic pain in women in the UK: a systematic review. Br. Obstet. Gynaecol (1998) 105(1):93–99.
   PubMedGoogle Scholar
• DAWOOD MY: Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhoea.Arm J. Med. (1988) 84\(Suppl. 5423–29.
   Google Scholar
• DAWOOD MY: Overall approach to the management of dysmenorrhoea.In: Dysmenorrhoea. Dawood MY (Ed.) Williams & Wilkins, Baltimore, USA (1981):261–279.
   Google Scholar
• SMITH RP: The use of nonsteroidal anti-inflammatory drugs in primary dysmenorrhoea. Int. Med. (1986) 169:22.
   Google Scholar
• CARRAHER R, HAHN DW,RITCHIE DM, MCGUIRE JL: Involvement of lipooxygenase products in myometrial contractions. Prostaglandins (1983) 26:23.
   PubMedGoogle Scholar
• REES MCP, DIMARZO V, TIPPINS JR, MORRIS HR, TURNBULL AC: Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia.Endocrinol (1987) 113:291.
   Google Scholar
• CHEGINI N, RAO CHV: The presence of leukotriene C4 and prostacyclin-binding sites in nonpregnant human uterine tissue. Clin. Endocrinol. Metab. (1988) 58:813.
   Google Scholar
• STROMBERG P, AKERLUND M, FORSLING ML, GRANSTROM E, KINDAHL H: Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhoea.Acta Obstet. Gynecol Scand. (1984) 63:533.
   PubMed Web of Science ®Google Scholar
• HAUKSSON A, AKERLUND M, MELIN P: Uterine blood flow and myometrial activity at menstruation and the action of vasopressin and a synthetic antagonist. &I. Obstet. Gynaecol (1988) 95:898.
   Google Scholar
• STROMBERG P, FORSLING M, AKERLUND M: Effect of prostaglandin inhibition of vasopressin levels in women with primary dysmenorrhoea.Obstet. Gynecol. (1981) 58:206.
   PubMed Web of Science ®Google Scholar
• DEMERS LM, HANN DW,MCGUIRE JL: Newer concepts in dysmenorrhoea research. In: Premenstrual Syndrome and Dysmenorrhoea. Dawood MJ, McGuire JL, Demers LM (Eds),Urban & Schwarzenburg, Baltimore, USA (1984):205.
   Google Scholar
• MONTRUCCHIO G, MASSOBRIO M, ALLOATTI G et al.: In vitro oxytocic activity of platelet-activating factor on human myometrium. In: Advancer in Prostaglandin, Thromboxane and Leukotriene Research. Samuelsson B, Paoletti R, Ramwell PW (Eds), New York, Raven Press (1987).
   Google Scholar
• MASSOBRIO M, BENEDETTO C, ROSI A, MAROZIO L, NIGAM S: Eicosanoids and platelet activating factor in dysmenorrhoea. In: Pain and Reproduction. Genazzani AR, Nappi G, Facchinetti F,Martignoni E (Eds), Parthenon Publishing, Carnforth (1988):63.
   Google Scholar
• WILLOUGHBY DA, MOORE AR, COLVILLE-NASH PR: COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet (2000) 355:646–668.
   PubMed Web of Science ®Google Scholar
• BOTTING RM: Mechanism of action of acetaminophen: is there acyclooxygenase 3? Clin. Infect. Dis. (2000) 31 (Suppl. 5):S202–S210.
   Google Scholar
• CHANDRASEKHARAN NV, DAI H, ROOS KL et al: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. ScL USA (2002) 99:13926–13931.
   PubMed Web of Science ®Google Scholar
• DINCHUK JE, LIU RQ, TRZASKOS JM: Cox-3: in the wrong frame in mind. ImmunoL Lett. (2003) 86(1) :121.
   PubMedGoogle Scholar
• CRAMER DW, HARLOW BL, TITUS-ERNSTOFF L, BOHLKE K, WELCH WR, GREENBERG ER:Over-the-counter analgesics and risk for ovarian cancer. Lancet (1998) 351:104–107.
   PubMed Web of Science ®Google Scholar
• JOBIN RM, NEUMANN CM,CHANG JP: Roles of calcium and calmodulin in the mediation of acute and sustained GnRH-stimulated gonadotropin secretion from dispersed goldfish pituitary cells. Gen. Comp. Endocrinol (1996)101:91–106.
   PubMedGoogle Scholar
• MUDGE GH: Diuretics.In: The Pharmacological Basis of Therapeutics (5th edit). Goodman LS, Gilman A (Eds), McGraw and Hill, UK
   Google Scholar
• OWEN PR: Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhoea. Am. J. °Intel-. Gynecol(1984) 148(1):96–103.
   PubMedGoogle Scholar
• SMITH RP: Drug therapy for dysmenorrhoea. Int. Med. J. (1986) 169(1):22–25.
   Google Scholar
• LAYES MOLLA A, DONALD LF: A comparative study of ibuprofen and acetaminophen in primary dysmenorrhoea.J. Int. Med. Res. (1974) 2(6):395–399.
   Google Scholar
• SEDGWICK JP, DAILY HR, LANGRICK AF, HILL RC:Double blind study of meptazinol, d-propoxyphene/acetominophen and placebo in patients with primary dysmenorrhoea. Curi: The]: Res. (1985) 38:528–535.
   Google Scholar
• ANDERSON AB, HAYNES PJ, FRASER IS, TURNBULL AC:Trial of prostaglandin-synthetase in primary dysmenorrhoea. Br. J. Clin. Pract. (1978) 1:345–348.
   Google Scholar
• LANGRICK AF, GUNN ADG:A comparison of naproxen sodium and a dextropropoxyphene/acetaminophen combination in the treatment of primary dysmenorrhoea in university health centers.Br: J. Clin. Pract. (1982) 36:181–184.
   PubMedGoogle Scholar
• WILLIAMS AA, BLACKHOUSE CI: A general practice study of naproxen sodium and a dextropropoxyphene- acetominophen combination in primary dysmenorrhea.Br: J. Clin. Pract. (1982) 36:383–385.
   PubMedGoogle Scholar
• DE LOS SANTOS AR,ZMIJANOVICH R, PEREZ MACRI S, MARTI ML, DI GIROLAMO G:Antispasmodic, analgesic association in primary dysmenorrhoea double/blind crossover placebo/controlled clinical trial.Int. J. Clin. Pharm. Res. (2001) 21(1):21–29.
   Google Scholar
• JANBU T, LOKKEN P, NESHEIM BI: Effect of acetylsalicylic acid, acetaminophen and placebo on pain and blood loss in dysmenorrhoeic women. Ear: J. Gin. Pharmacol (1978) 14(6):413–416.
   Google Scholar
• MACLEAN D: A comparison of flurfiprofen and acetaminophen in the treatment of primary dysmenorrhoea.J. Int. Med. Res. (1983) 11 (2) : 1–5.
   Google Scholar
• FRANK GJ, KEFFORD RH:Report of a double-blind crossover study to compare flurbiprofen with acetaminophen in the treatment of primary dysmenorrhoea.J. Int. Med. Res. (1983) 11(2):6–10.
   Google Scholar
• MILSOM I, ANDERSCH B:Effect of ibuprofen, naproxen sodium and acetaminophen on intrauterine pressure and menstrual pain in dysmenorrhoea.Br: J. Obstet. Gynaecol (1984)91(11):1129–1135.
   Google Scholar
• PENDERGRASS PB, SCOTT JN, REAM LJ, AGNA MA: Effect of small doses of aspirin and acetaminophen on total menstrual loss and pain of cramps and headache. Gynecol °Intel-. Invest. (1985) 19(1):32–37.
   Google Scholar
• ZHANG WY, LI WAN, PO A: Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. Br: J. Obstet. Gynecol (1998)105(7):780–789.
   PubMedGoogle Scholar
• MORRISON BW, DANIELS SE, KOTEY P, CANTU N, SEIDENBERG B:Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea:a randomized controlled trial.Gynecol (1999) 94(4):504–508.
   Google Scholar
• MCADAM BE CATELLA-LAWSON F, MARDINI IA, KAPOOR S, LAWSON JA, FITZGERALD GA: Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Nati Acad. Sci. USA (1999) 96(1):272–277; Erratum in Proc. Natl. Acad. Sci. USA (1999) 96(10):5890.
   Google Scholar
• MONCADA S, VANE JR: Pharmacology and endogenous roles of prostaglandin endoperwddes, thromboxane A2, and prostacyclin. Pharmacol Rev (1978) 30(3):293–331.
   PubMedGoogle Scholar
• BRATER DC: Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am. J. Med. (1999) 107(6A):565–570.
   Google Scholar
• MILSOM I, MINIC M, DAWOOD Y et al: Comparison of the efficacy and safety of nonprescription dosed of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhoea: a pooled analysis of five studies.Clin. Ther. (2002) 24(9):1384–1400.
   Google Scholar
• HERSH EV, MOORE PA, ROSS GL: Over-the-counter analgesics and antipyretics: a critical assessment.Clin. Ther. (2000) 22(5):500–548.
   Google Scholar
• MYERS WC, OTTO TA, HARRIS E et al: Acetaminophen overdose as a suicidal gesture: a survey of adolescent's knowledge of its potential toxicity. J. Am. Acad. Child Adolesc. Psychiatry (1992) 31:686–690.
   PubMed Web of Science ®Google Scholar
• KEAYS R, WILLIAMS R:Acetaminophen poisoning and liver failure.Prescr. J(1989) 29:1 55–16 2.
   Google Scholar
• MAKIN AJ, WEND ON J, WILLIAMS R: Management of severe cases of paracetamol overdosage. Br. J. Hosp. Med. (1994) 52:210–213.
   PubMed Web of Science ®Google Scholar
• JANES J, ROUTLEDGE PA:Recent developments in the management of paracetamol (acetaminophen) poisoning. Drug Sal (1992) 7:170–177.
   PubMed Web of Science ®Google Scholar
• CRIPPIN JS: Acetaminophenhepatotoxicity: potentiation by isoniazid.Am.j GastroenteroL (1993) 88:590–592.
   PubMed Web of Science ®Google Scholar
• NOLAN CM, SANDBLOM RE, THUMMEL KE, SLATTERY JT, NELSON SD: Hepatotoxicity associated with acetaminophen usage in patientsreceiving multiple drug therapy for tuberculosis. Chest (1994) 105:408–411.
   PubMed Web of Science ®Google Scholar
• KARAKAYA G, KALYONCU AF: Acetaminophen and asthma. Expert Opin. Pharmacether: (2003) 4(1):13–21.
   PubMed Web of Science ®Google Scholar
• COHEN HA, NUSSINOVITCH M, FRYDMAN M: Fixed drug eruption caused by acetaminophen. Ann. Pharmacether. (1992) 26:1596–1597.
   PubMedGoogle Scholar
• HERN S, HARMAN K, CLEMENT M, BLACK MM: Bullous fixed drug eruption due to acetaminophen with an unusual immunofluorescence pattern.Br: J. Dermatel (1998) 139:1129–1131.
   PubMedGoogle Scholar
• VAN DIEM L, GRILLIAT JP: Anaphylactic shock induced by acetaminophen. Eur: Clin. Pharmacy]. (1990) 38:389–390.
   PubMedGoogle Scholar
• NEDOROST SM, TAYLOR JS, CAMISA C, TOME CKI KJ, HELM T, DURKIN WJ: Fixed drug eruption from pamabrom. Cleve. Clin. J. Med. (1991) 58(1):64–65.
   PubMedGoogle Scholar
• CREATSAS GE, DELIGEOROGOU E et al.: Prostaglandins PGF2a, PGE2, 6 -keto PGF la and TXB2 serum levels in dysmenorrhoeic adolescence before, duringand after treatment with oral contraceptives. Eur. Obstet. Gynecel Repred. Biel (1990) 36:292–298.
   PubMed Web of Science ®Google Scholar
• GEBHART GF, MCCORMACK KJ: Neuronal plasticity. Implication for pain therapy. Drug (1994) 47\(Suppl. 5):1–47.
   Google Scholar
• HERNANDEZ BUENO JA,DE LA JARA DIAZ J, SEDENO CRUZ F, LLORENS TORRES F: Analgesic—antispasmodic effect and safety of lysine clonixinate and L-hyoscinbutylbromide in the treatment of dysmenorrhoea. Ginecel °Enter Mex. (1998) 66:35–39.
   PubMedGoogle Scholar
• KAPLAN B, RABINERSON D, LURIE S et al: Clinical evaluation of e new model of transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhoea. Gynecel °Enter Invest. (1997) 44(4):255–259.ao.TSENOV D: The effect of acupuncture indysmenorrhoea. Akusk Ginecel Sefflia(1996) 35(3):24–25.
   Google Scholar
• PICCIONE E, NOCCIOLI G, CASSADEI L, SESTI F: Attuali aspetti di terapia medica della dismenorrea. Gier. It. Ost. Gyn. (1988) 4:277–281.
   Google Scholar
• GRANOT M, YARNITSKY D,ITSKOVITZ-ELDOR J, GRANOVSKY Y, PEER E, ZIMMER EZ: Pain perception in women with dysmenorrhoea.Obstet. Gynecel (2001) 98 (3) :407–411.
   Google Scholar